Nicholas A. Smith

Array ( [id] => 9184074 [patent_doc_number] => 08624007 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-07 [patent_title] => 'Alteration of Fc-fusion protein serum half-lives by mutagenesis' [patent_app_type] => utility [patent_app_number] => 12/751914 [patent_app_country] => US [patent_app_date] => 2010-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 21411 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12751914 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7719854 [patent_doc_number] => 20120009189 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-12 [patent_title] => 'ANTIBODY COMPOSITION WITH ALTERED FAB SIALYLATION' [patent_app_type] => utility [patent_app_number] => 13/260202 [patent_app_country] => US [patent_app_date] => 2010-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14196 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20120009189.pdf [firstpage_image] =>[orig_patent_app_number] => 13260202 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8042175 [patent_doc_number] => 20120070819 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-22 [patent_title] => 'Determination of Interactions of Constant Parts of Antibodies with FC-Gamma Receptors' [patent_app_type] => utility [patent_app_number] => 13/257119 [patent_app_country] => US [patent_app_date] => 2010-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9378 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20120070819.pdf [firstpage_image] =>[orig_patent_app_number] => 13257119 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6633764 [patent_doc_number] => 20100311954 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'Optimized Proteins that Target Ep-CAM' [patent_app_type] => utility [patent_app_number] => 12/724309 [patent_app_country] => US [patent_app_date] => 2010-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 46 [patent_no_of_words] => 45215 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20100311954.pdf [firstpage_image] =>[orig_patent_app_number] => 12724309 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8239856 [patent_doc_number] => 20120148576 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-14 [patent_title] => 'HUMANIZED ANTI-CD 19 ANTIBODY FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 13/254656 [patent_app_country] => US [patent_app_date] => 2010-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 97017 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13254656 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7656424 [patent_doc_number] => 20110305693 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => 'ANITIGEN-BINDING CONSTRUCTS' [patent_app_type] => utility [patent_app_number] => 13/202998 [patent_app_country] => US [patent_app_date] => 2010-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 22692 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20110305693.pdf [firstpage_image] =>[orig_patent_app_number] => 13202998 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7656423 [patent_doc_number] => 20110305692 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => 'ANTIGEN-BINDING CONTRUCTS' [patent_app_type] => utility [patent_app_number] => 13/202996 [patent_app_country] => US [patent_app_date] => 2010-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 23278 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20110305692.pdf [firstpage_image] =>[orig_patent_app_number] => 13202996 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6339232 [patent_doc_number] => 20100247431 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'POLYPEPTIDES INCLUDING MODIFIED CONSTANT REGIONS' [patent_app_type] => utility [patent_app_number] => 12/701729 [patent_app_country] => US [patent_app_date] => 2010-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 9660 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20100247431.pdf [firstpage_image] =>[orig_patent_app_number] => 12701729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6571401 [patent_doc_number] => 20100234575 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'FC VARIANTS WITH ALTERED BINDING TO FCRN' [patent_app_type] => utility [patent_app_number] => 12/697960 [patent_app_country] => US [patent_app_date] => 2010-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 26391 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20100234575.pdf [firstpage_image] =>[orig_patent_app_number] => 12697960 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6540909 [patent_doc_number] => 20100204454 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'Fc Variants with altered binding to FcRn' [patent_app_type] => utility [patent_app_number] => 12/697933 [patent_app_country] => US [patent_app_date] => 2010-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 26395 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20100204454.pdf [firstpage_image] =>[orig_patent_app_number] => 12697933 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8543615 [patent_doc_number] => 08318907 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-27 [patent_title] => 'Fc variants with altered binding to FcRn' [patent_app_type] => utility [patent_app_number] => 12/697945 [patent_app_country] => US [patent_app_date] => 2010-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 35 [patent_no_of_words] => 26402 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12697945 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8549469 [patent_doc_number] => 08324351 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-04 [patent_title] => 'Fc variants with altered binding to FcRn' [patent_app_type] => utility [patent_app_number] => 12/697952 [patent_app_country] => US [patent_app_date] => 2010-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 32 [patent_no_of_words] => 26214 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12697952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8571926 [patent_doc_number] => 08338574 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-25 [patent_title] => 'FC variants with altered binding to FCRN' [patent_app_type] => utility [patent_app_number] => 12/697903 [patent_app_country] => US [patent_app_date] => 2010-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 35 [patent_no_of_words] => 26186 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12697903 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10857771 [patent_doc_number] => 08883973 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-11 [patent_title] => 'Fc variants with altered binding to FcRn' [patent_app_type] => utility [patent_app_number] => 12/697939 [patent_app_country] => US [patent_app_date] => 2010-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 32 [patent_no_of_words] => 26412 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12697939 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7573097 [patent_doc_number] => 20110268753 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => 'PROCESS FOR REGULATING IMMUNE RESPONSE' [patent_app_type] => utility [patent_app_number] => 13/143835 [patent_app_country] => US [patent_app_date] => 2010-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11499 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0268/20110268753.pdf [firstpage_image] =>[orig_patent_app_number] => 13143835 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6519000 [patent_doc_number] => 20100203046 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'FC GAMMA RECEPTOR-BINDING POLYPEPTIDE VARIANTS AND METHODS RELATED THERETO' [patent_app_type] => utility [patent_app_number] => 12/652445 [patent_app_country] => US [patent_app_date] => 2010-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 42721 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20100203046.pdf [firstpage_image] =>[orig_patent_app_number] => 12652445 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6518988 [patent_doc_number] => 20100203045 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'EPH RECEPTOR Fc VARIANTS WITH ENHANCED ANTIBODY DEPENDENT CELL-MEDIATED CYTOTOXICITY ACTIVITY' [patent_app_type] => utility [patent_app_number] => 12/631616 [patent_app_country] => US [patent_app_date] => 2009-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 55759 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20100203045.pdf [firstpage_image] =>[orig_patent_app_number] => 12631616 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6548525 [patent_doc_number] => 20100233079 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'Dual Variable Domain Immunoglobulins and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/631483 [patent_app_country] => US [patent_app_date] => 2009-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 90852 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 34 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20100233079.pdf [firstpage_image] =>[orig_patent_app_number] => 12631483 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6430916 [patent_doc_number] => 20100143353 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'POLYPEPTIDES COMPRISING Fc FRAGMENTS OF IMMUNOGLOBULIN G (lgG) AND METHODS OF USING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/629136 [patent_app_country] => US [patent_app_date] => 2009-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 115 [patent_figures_cnt] => 115 [patent_no_of_words] => 18708 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20100143353.pdf [firstpage_image] =>[orig_patent_app_number] => 12629136 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7669071 [patent_doc_number] => 20110318340 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'DEGLYCOSYLATED ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 13/129788 [patent_app_country] => US [patent_app_date] => 2009-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 21083 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13129788 [rel_patent_id] =>[rel_patent_doc_number] =>)